Shockwave Medical
Shockwave Medical, part of Johnson & Johnson MedTech, is a leader in the development and commercialization of innovative products that are transforming the treatment of cardiovascular disease. Its first-of-its-kind Intravascular Lithotripsy (IVL) technology has transformed the treatment of atherosclerotic cardiovascular disease by using sonic pressure waves to disrupt challenging calcified plaque, resulting in significantly improved patient outcomes. Its Reducer technology, which is under clinical investigation in the United States and is CE Marked in the European Union and the United Kingdom, is designed to provide relief to the millions of patients worldwide suffering from refractory angina by redistributing blood flow within the heart. Learn more at www.shockwavemedical.com.
Managing Calcification in Aortoiliac Disease and Challenging EVAR/TEVAR Access with IVL
Dr. Frank R. Arko III presents, “Managing Calcification in Aortoiliac Disease and Challenging EVAR/TEVAR Access with IVL: A Vascular Surgeon’s Perspective.”
Recorded in an Endovascular Today Webinar sponsored by Shockwave Medical.
Shockwave IVL Important Safety Information: https://shockwavemedical.com/important-safety-information/
